QABGX
Price
$23.75
Change
+$0.07 (+0.30%)
Updated
Oct 8 closing price
Net Assets
297.38M
RLBAX
Price
$38.73
Change
+$0.17 (+0.44%)
Updated
Oct 8 closing price
Net Assets
266.1B
Interact to see
Advertisement

QABGX vs RLBAX

Header iconQABGX vs RLBAX Comparison
Open Charts QABGX vs RLBAXBanner chart's image
Federated Hermes MDT Balanced A
Price$23.75
Change+$0.07 (+0.30%)
VolumeN/A
Net Assets297.38M
American Funds American Balanced R1
Price$38.73
Change+$0.17 (+0.44%)
VolumeN/A
Net Assets266.1B
QABGX vs RLBAX Comparison Chart in %
View a ticker or compare two or three
VS
QABGX vs. RLBAX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QABGX is a Buy and RLBAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 266B vs. QABGX (297M). QABGX pays higher dividends than RLBAX: QABGX (1.20) vs RLBAX (1.10). QABGX was incepted earlier than RLBAX: QABGX (20 years) vs RLBAX (23 years). QABGX (1.37) and RLBAX (1.31) have similar cost to investors . QABGX is a more actively managed with annual turnover of: 68.00 vs. RLBAX (44.00). RLBAX has a lower initial minimum investment than QABGX: RLBAX (250) vs QABGX (1500). RLBAX annual gain was more profitable for investors over the last year : 9.08 vs. QABGX (3.33). RLBAX return over 5 years is better than : 38.13 vs. QABGX (23.20).
QABGXRLBAXQABGX / RLBAX
Total Expense Ratio1.341.31102%
Annual Report Gross Expense Ratio1.371.31105%
Fund Existence20 years23 years-
Gain YTD11.59314.27181%
Front Load5%N/A-
Min. Initial Investment1500250600%
Min. Initial Investment IRAN/AN/A-
Net Assets297M266B0%
Annual Yield % from dividends1.201.10109%
Returns for 1 year3.339.0837%
Returns for 3 years35.7048.6473%
Returns for 5 years23.2038.1361%
Returns for 10 years59.5069.4686%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IVP0.990.01
+1.31%
Inspire Veterinary Partners Inc
GRRR20.220.23
+1.15%
Gorilla Technology Group
ROIV16.03-0.09
-0.56%
Roivant Sciences Ltd
PRLD1.42-0.02
-1.39%
Prelude Therapeutics
WLY36.77-1.56
-4.07%
John Wiley & Sons